Erratum: Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma (Blood Advances (2018) 2:16 (2039-2051) DOI: 10.1182/bloodadvances.201801604)

Jimmy Lee*, Liang Leo Zhang, Wenjun Wu, Hui Guo, Yan Li, Madina Sukhanova, Girish Venkataraman, Shengjian Huang, Hui Zhang, Mir Alikhan, Pin Lu, Ailin Guo, Natalie Galanina, Jorge Andrade, Michael L. Wang, Y. Lynn Wang

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

On page 2049, under "Authorship," the contribution paragraph should read, "Y.L.W. formed the hypothesis and directed the project; J.L., L.L.Z., W.W., H.G., M.S., G.V., S.H., H.Z., P.L., A.G., and N.G. developed the assays, designed and performed the experiments, solved technical problems, and analyzed the data; M.A. participated in IHC review and data presentation; L.L.Z., M.S., G.V., and M.L.W. contributed useful patient materials and patient pathological and treatment information; L.L.Z. and M.L.W. designed and performed the PDX study; Y.L. and J.A. performed bioinformatics analyses on the RNA-Seq data; J.L. L.L.Z., P.L., and J.A. participated in the manuscript writing; and Y.L.W. directed and coordinated the project, designed the experiments, analyzed the data, and wrote the manuscript." The errors have been corrected in the published article.

Original languageEnglish (US)
Pages (from-to)2588
Number of pages1
JournalBlood Advances
Volume2
Issue number20
DOIs
StatePublished - Oct 23 2018

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Erratum: Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma (Blood Advances (2018) 2:16 (2039-2051) DOI: 10.1182/bloodadvances.201801604)'. Together they form a unique fingerprint.

Cite this